Business Context and Reporting Period
This Form 8-K is a current report filed by Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) on August 30, 2007. The filing discloses the resignation of Dr. Eric M. Millar, the Company's Senior Vice President – Operations, and details the terms of his separation agreement.
Key Financial Metrics
The filing does not provide general financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific compensation arrangement for the departing executive:
- Work At Home Salary: $213,000 annual rate for a one-year period.
- Severance Bonus: A payment equivalent to the greater of the prior year's actual bonus or a target bonus of 45% of the Work At Home salary, payable on or about May 1, 2008.
- Equity: Carried Shares will continue to vest on a straight-line pro rata basis through the expiration of the one-year Work At Home Period.
Material Changes
The primary material change is the departure of a senior executive. Dr. Millar will resign as an officer on a date chosen by the Company, but no later than September 30, 2007. During the transition, his responsibilities are limited to handing over his position. He will not be eligible for future Long-Term Incentive Awards in calendar years 2007 and 2008.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies regarding the executive's compensation and equity:
- Change in Control: In the event of a change in control, all unvested Carried Shares shall immediately vest.
- Death or Disability: If Dr. Millar dies or becomes disabled during the Work At Home Period, all amounts payable under the agreement shall be paid as though he had fully performed his obligations, and all unvested shares will immediately vest.
- Restrictions: The agreement includes customary confidentiality and non-competition provisions.
Investor Verification Checklist
- Verify the exact resignation date of Dr. Millar, which is to be determined by the Company but must occur before September 30, 2007.
- Confirm the total number of Carried Shares held by Dr. Millar to assess the potential dilution or repurchase impact.
- Review the Company's subsequent filings to identify the replacement for the Senior Vice President – Operations role.
- Monitor the Company's cash flow statements in the fiscal year ending March 31, 2008, for the impact of the severance bonus payment.